反应详情

A mixture of (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-(4-chloro-2-butynyl)-2-(2-naphthylmethyl)piperazine (600 mg), 3,3-dimethylmorpholine hydrochloride (197 mg) and potassium carbonate (420 mg) in N,N-dimethylformamide (10 ml) was stirred at room temperature in the presence of potassium iodide (10 mg) for 2 days. The reaction mixture was partitioned between ethyl acetate (50 ml) and water (100 ml) and the organic layer was separated, washed with brine and dried over magnesium sulfate. After evaporation of the solvent, the residue was purified by column chromatography on silica gel using a mixture of ethyl acetate-hexane (10:1). The obtained product was dissolved in ethyl acetate and treated with 4N hydrogen chloride in ethyl acetate to give (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[4-(3,3-dimethylmorpholino)-2-butynyl]-2-(2-naphthylmethyl)piperazine dihydrochloride (360 mg).

1. customThe reaction mixture was partitioned between ethyl acetate (50 ml) and water (100 ml)
2. customthe organic layer was separated
3. washwashed with brine
4. dry with materialdried over magnesium sulfate
5. customAfter evaporation of the solvent
6. customthe residue was purified by column chromatography on silica gel using
7. additiona mixture of ethyl acetate-hexane (10:1)
8. dissolutionThe obtained product was dissolved in ethyl acetate
9. additiontreated with 4N hydrogen chloride in ethyl acetate